Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2014

Apr 28, 2014

5262_dirs_2014-04-28_26267c17-b317-4bbb-af34-9217683f006f.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6867F

GlaxoSmithKline PLC

28 April 2014

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Following a revaluation of the cash element of the notional investment held within the GSK 401K plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 28 April 2014 of the following increase in the notional allocation of ADSs on 25 April 2014 at a price of $55.76 per ADS:-

Director/PDMR Number of ADSs Connected Person Number of ADSs
Dr M Slaoui - Dr K Slaoui 3

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

28 April 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZVLFLZZFXBBE